Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer.

MLA

Złowocka, Elzbieta, et al. “Germline Mutations in the CHEK2 Kinase Gene Are Associated with an Increased Risk of Bladder Cancer.” International Journal of Cancer, vol. 122, no. 3, Feb. 2008, pp. 583–86. EBSCOhost, https://doi.org/10.1002/ijc.23099.

APA

Złowocka, E., Cybulski, C., Górski, B., Debniak, T., Słojewski, M., Wokołorczyk, D., Serrano-Fernández, P., Matyjasik, J., van de Wetering, T., Sikorski, A., Scott, R. J., & Lubiński, J. (2008). Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer. International Journal of Cancer, 122(3), 583–586. https://doi.org/10.1002/ijc.23099

Chicago

Złowocka, Elzbieta, Cezary Cybulski, Bohdan Górski, Tadeusz Debniak, Marcin Słojewski, Dominika Wokołorczyk, Pablo Serrano-Fernández, et al. 2008. “Germline Mutations in the CHEK2 Kinase Gene Are Associated with an Increased Risk of Bladder Cancer.” International Journal of Cancer 122 (3): 583–86. doi:10.1002/ijc.23099.